Page last updated: 2024-10-23

aztreonam and Dementia

aztreonam has been researched along with Dementia in 1 studies

Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.

Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.

Research Excerpts

ExcerptRelevanceReference
"Aztreonam is a safe, well-tolerated antibiotic with a good response in psychogeriatric patients."1.28Clinical use of aztreonam in a psychogeriatric population. ( Roelandts, F, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Roelandts, F1

Other Studies

1 other study available for aztreonam and Dementia

ArticleYear
Clinical use of aztreonam in a psychogeriatric population.
    Acta clinica Belgica, 1992, Volume: 47, Issue:4

    Topics: Aged; Aztreonam; Bacterial Infections; Dementia; Drug Therapy, Combination; Female; Floxacillin; Hum

1992